[144] Parker-Hannifin Corporation SEC Filing
Rhea-AI Filing Summary
Form 144 filed for Parker-Hannifin Corporation (PH) reporting a proposed sale of 995 common shares through broker Kestra on the NYSE with an approximate sale date of 08/08/2025. The filing lists an aggregate market value of $702,000.00 and 128,410,000 shares outstanding.
All 995 shares were acquired as stock awards from the issuer: 660 shares on 02/24/2024 and 335 shares on 04/25/2024. The filer reports Nothing to Report for securities sold in the past three months and includes the standard representation regarding lack of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small proposed sale of 995 shares from recent stock awards; negligible relative to total outstanding shares.
The filing documents a proposed sale of 995 common shares (aggregate market value $702,000) to occur on 08/08/2025 via broker Kestra. Acquisition details show the shares were granted as stock awards on 02/24/2024 (660 shares) and 04/25/2024 (335 shares). No sales in the past three months are reported. Given the scale relative to the 128,410,000 shares outstanding, the transaction appears administratively routine and unlikely to affect market valuation.
TL;DR: Transaction stems from issuer stock awards and includes standard signer representations; no red flags in the notice.
The notice indicates the securities were acquired from the issuer as compensation, consistent with executive/employee equity programs. The filer certifies no undisclosed material adverse information and reports no prior three-month sales. Broker and exchange details are provided (Kestra; NYSE). From a governance perspective, this is a routine disclosure of a planned sale of awarded shares.